[Skip to Content]
[Skip to Content Landing]
Comment & Response
December 2013

IgG4-Related Skin Disease

Author Affiliations
  • 1Department of Dermatology, Mayo Clinic, Rochester, Minnesota
  • 2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Dermatol. 2013;149(12):1439-1440. doi:10.1001/jamadermatol.2013.7326

To the Editor We read with interest the article recently published in JAMA Dermatology that reported successful treatment of IgG4-related disease (IgG4-RD) of the skin with thalidomide.1 A recently described disease entity, IgG4-RD can affect virtually any organ of the body, and while skin involvement is rare, it may manifest clinically as nonspecific skin papules, plaques, and nodules.2 Ingen-Housz-Oro et al1 rendered a diagnosis of IgG4-RD in the skin of 2 patients with skin nodules based on evaluation of skin biopsy specimens showing dense lymphocytic infiltrates with lymphoid follicles, dermal fibrosis, and a IgG4 to IgG ratio exceeding 75%. Although these patients may indeed have had isolated skin involvement by IgG4-RD, we highlight herein recent advances in the diagnosis of IgG4-RD to emphasize the importance of correlating clinical features, histopathologic evidence, and immunophenotypic data derived from careful interpretation of IgG4 and IgG stains.

First Page Preview View Large
First page PDF preview
First page PDF preview